Terrible optics: AstraZeneca shares take a hit following report that CEO Soriot is moving to Teva
You can insert this story in the WTF? file.
Wednesday afternoon Israel’s Calcalist reported that AstraZeneca CEO Pascal Soriot has agreed to take the CEO’s job at Teva, filling a role left open at a company that is in the middle of a major upheaval.
The Israeli financial news web site says that Soriot has personally signed off on the new job, accepting a $20 million bonus, according to a story from Reuters. And Haaretz followed up with its own confirmation that Soriot has agreed to take the Teva job, the second non-Israeli to take the position, though they are still discussing terms. The Haaretz report also included word of the $20 million bonus.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.